Used in pharmaceutical synthesis as an intermediate for developing biologically active compounds, particularly in the production of kinase inhibitors and other therapeutic agents targeting cancer and inflammatory diseases. Its structure supports the formation of guanidine-containing molecules, which are known for strong hydrogen bonding and improved target binding in drug design. Also employed in research settings to develop novel analogs with enhanced metabolic stability and bioavailability.